« Back
Home /
Gemcitabine

Gemcitabine

Item no.	TMO-T0251-1g
Manufacturer	TargetMol
CASRN	95058-81-4
Amount	1 g
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 2 mg 500 mg 50 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.67%
Citations	Yip-Schneider MT, et al. Dimethylaminoparthenolide and Gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer. BMC Cancer. 2013 Apr 17;13:194.
Smiles	NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	NSC 613327,LY188011
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Autophagy\|\|\|DNA/RNA Synthesis\|\|\|Apoptosis\|\|\|Nucleoside Antimetabolite/Analog
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	263.2
Description	Gemcitabine (LY188011) is a synthetic cytosine nucleoside derivative and an inhibitor of DNA synthesis. Gemcitabine has antitumor and antimetabolic activities. Gemcitabine induces autophagy and apoptosis.
Pathways	Cell Cycle/Checkpoint\|\|\|DNA Damage/DNA Repair\|\|\|Apoptosis\|\|\|Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T0251-1g-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 1 g

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question